[1]
« Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men », Can Diabetes Endocrinol Today, vol. 2, nᵒ 3, p. 5–10, nov. 2024, doi: 10.58931/cdet.2024.2330.